Accidental Injuries
Conditions
Interventions
This will be a randomized clinical trial with triple blinding, in which the researcher responsible for administering the instruments, the skin assessor, and the statisticians in charge of data analysi
and the control group (CG), composed of 102 patients who will undergo removal of the compression dressing using bath water and soap, the standard procedure adopted by the institution.The randomization
Sponsors
Hospital das Clínicas da Universidade Federal do Triângulo Mineiro
Universidade Federal do Triângulo Mineiro
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Individuals of both sexes; aged 18 years or older; who have undergone compression dressings with medical adhesives following endovascular procedures; elective or emergency procedures; hospitalized after the procedure
Exclusion criteria
Exclusion criteria: Presence of previous skin lesions or lesions adjacent to the area where the compressive dressing will be applied
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected that the use of Dermilon® removal solution will reduce the incidence of Medical Adhesive-Related Skin Injury (MARSI) by 43.5% in patients undergoing endovascular procedures, compared to those who do not use the solution. | — |
Secondary
| Measure | Time frame |
|---|---|
| It is also expected that the incidence of Medical Adhesive-Related Skin Injury (MARSI) will be significantly higher among patients classified as high risk according to the MARSI Risk Assessment Scale. | — |
Countries
Brazil
Contacts
Public ContactPrograma de Pos Graduacao em Atencao a Saude Universidade Federal de UIberaba
Universidade Federal do Triângulo Mineiro
Outcome results
None listed